Cardiol Therapeutics Inc. Class A · TSX:CRDL
Cardiol Therapeutics Inc. Class A shareholders
As of Jun 30, 2026, 52 institutions reported holding Cardiol Therapeutics Inc. Class A, 24.3% of its shares. Largest: MMCAP International Inc. SPC, Tejara Capital Ltd and Ikarian Capital, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cardiol Therapeutics Inc. Class A | Change | Filed |
|---|---|---|---|---|
| MMCAP International Inc. SPC | 15.6M | 12.8% | +246K | Aug 14, 2026 |
| Tejara Capital Ltd | 5.11M | 4.2% | −16,300 | Aug 11, 2026 |
| Ikarian Capital, LLC | 3.33M | 2.7% | +600K | Aug 14, 2026 |
| Boothbay Fund Management, LLC | 976K | 0.80% | +181K | Aug 14, 2026 |
| Citadel | 797K | 0.66% | −23,375 | Aug 14, 2026 |
| Renaissance Technologies | 773K | 0.64% | +543K | Aug 13, 2026 |
| Two Sigma | 747K | 0.61% | +213K | Aug 14, 2026 |
| Integrity Alliance, LLC. | 388K | 0.32% | −76,533 | Jul 31, 2026 |
| Morgan Stanley | 355K | 0.29% | +105K | Aug 13, 2026 |
| Goldman Sachs | 334K | 0.27% | +1,500 | Aug 14, 2026 |